Live / Fauci testifies before Senate on Covid pandemic
Digest more
Fauci received his first COVID-19 vaccine in December 2020, around six months before his doctors discovered lung tissue death.
WASHINGTON — A War Department program requested proposals for so-called “gain of function” experiments that could make viruses more infectious nearly two full years before the COVID-19 pandemic began,
It wouldn't be surprising for a summer increase in COVID to begin now. Large numbers of people haven't fallen ill with COVID for quite a while.
Rand Paul reveals documents showing CBP intercepted undeclared biological materials tied to a U.S.-China coronavirus research network as early as 2018.
Centers for Disease Control and Prevention researchers report national estimates of 43.6 million COVID-19-associated illnesses and 101,300 deaths in the US during October 2022 to September 2023, plus 33.0 million illnesses and 100,800 deaths during October ...
Traces of the pandemic are still plenty present in the Bayou City.
3don MSN
Exclusive: Alleged $32M COVID-19 fraud fugitive captured in Jamaica and returned to US, FBI says
Elaine Angene Escoe was living under the fake identity "Harley Newman" in Jamaica before her arrest in connection with a $32 million COVID-19 fraud scheme.
Since Dr. Anthony Fauci retired late last year as head of the National Institute of Allergy and Infectious Diseases, effectively ending his role as America’s Doctor during the Covid-19 public health emergency, he has been reflecting in a series of new ...
School closures during the COVID-19 pandemic imposed enormous long-term costs while other measures delivered better health outcomes for far less money, according to new research led by Oxford University's Department of Statistics and the Leverhulme Center ...
Shionogi’s oral main protease inhibitor Xocova (ensitrelvir) is now available in the US to reduce the risk of symptomatic COVID-19 following exposure in adults and adolescents aged 12 and older.
Shionogi Inc., a New Jersey-based subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, PhD; hereinafter "Shionogi") announced U.S. availability of XOCOVA® (ensitrelvir),